These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27399248)

  • 1. High-resolution arrays reveal burden of copy number variations on Parkinson disease genes associated with increased disease risk in random cohorts.
    Murthy MN; Veerappa AM; Seshachalam KB; Ramachandra NB
    Neurol Res; 2016 Sep; 38(9):775-85. PubMed ID: 27399248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural genomic variations and Parkinson's disease.
    Bandrés-Ciga S; Ruz C; Barrero FJ; Escamilla-Sevilla F; Pelegrina J; Vives F; Duran R
    Minerva Med; 2017 Oct; 108(5):438-447. PubMed ID: 28541025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution survey in familial Parkinson disease genes reveals multiple independent copy number variation events in PARK2.
    Wang L; Nuytemans K; Bademci G; Jauregui C; Martin ER; Scott WK; Vance JM; Zuchner S
    Hum Mutat; 2013 Aug; 34(8):1071-4. PubMed ID: 23616242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.
    Kay DM; Stevens CF; Hamza TH; Montimurro JS; Zabetian CP; Factor SA; Samii A; Griffith A; Roberts JW; Molho ES; Higgins DS; Gancher S; Moses L; Zareparsi S; Poorkaj P; Bird T; Nutt J; Schellenberg GD; Payami H
    Neurology; 2010 Sep; 75(13):1189-94. PubMed ID: 20876472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of Parkinson disease.
    Domingo A; Klein C
    Handb Clin Neurol; 2018; 147():211-227. PubMed ID: 29325612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder.
    Jarick I; Volckmar AL; Pütter C; Pechlivanis S; Nguyen TT; Dauvermann MR; Beck S; Albayrak Ö; Scherag S; Gilsbach S; Cichon S; Hoffmann P; Degenhardt F; Nöthen MM; Schreiber S; Wichmann HE; Jöckel KH; Heinrich J; Tiesler CM; Faraone SV; Walitza S; Sinzig J; Freitag C; Meyer J; Herpertz-Dahlmann B; Lehmkuhl G; Renner TJ; Warnke A; Romanos M; Lesch KP; Reif A; Schimmelmann BG; Hebebrand J; Scherag A; Hinney A
    Mol Psychiatry; 2014 Jan; 19(1):115-21. PubMed ID: 23164820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copy number variation in familial Parkinson disease.
    Pankratz N; Dumitriu A; Hetrick KN; Sun M; Latourelle JC; Wilk JB; Halter C; Doheny KF; Gusella JF; Nichols WC; Myers RH; Foroud T; DeStefano AL;
    PLoS One; 2011; 6(8):e20988. PubMed ID: 21829596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes mellitus disease risk genes identified by genome wide copy number variation scan in normal populations.
    Prabhanjan M; Suresh RV; Murthy MN; Ramachandra NB
    Diabetes Res Clin Pract; 2016 Mar; 113():160-70. PubMed ID: 26830856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?
    Sutherland GT; Halliday GM; Silburn PA; Mastaglia FL; Rowe DB; Boyle RS; O'Sullivan JD; Ly T; Wilton SD; Mellick GD
    Mov Disord; 2009 Apr; 24(6):833-8. PubMed ID: 19224617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy number variability in Parkinson's disease: assembling the puzzle through a systems biology approach.
    La Cognata V; Morello G; D'Agata V; Cavallaro S
    Hum Genet; 2017 Jan; 136(1):13-37. PubMed ID: 27896429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of copy number variations burden on coding genome in humans using integrated high resolution arrays.
    Veerappa AM; Lingaiah K; Vishweswaraiah S; Murthy MN; Suresh RV; Manjegowda DS; Ramachandra NB
    Genet Res (Camb); 2014 Dec; 96():e17. PubMed ID: 25578402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide analysis of copy number variations identifies PARK2 as a candidate gene for autism spectrum disorder.
    Yin CL; Chen HI; Li LH; Chien YL; Liao HM; Chou MC; Chou WJ; Tsai WC; Chiu YN; Wu YY; Lo CZ; Wu JY; Chen YT; Gau SS
    Mol Autism; 2016; 7():23. PubMed ID: 27042285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathogenesis of Parkinson's disease: update.
    Saiki S; Sato S; Hattori N
    J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):430-6. PubMed ID: 22138181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Leucine-rich repeat kinase 2 (LRRK2) and Parkinson protein 2 (parkin, PARK2) genes mutations in Slovak Parkinson disease patients.
    Bognar C; Baldovic M; Benetin J; Kadasi L; Zatkova A
    Gen Physiol Biophys; 2013 Mar; 32(1):55-66. PubMed ID: 23531835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence of known pathogenic mutations in dominant PD genes: A Swedish multicenter study.
    Puschmann A; Jiménez-Ferrer I; Lundblad-Andersson E; Mårtensson E; Hansson O; Odin P; Widner H; Brolin K; Mzezewa R; Kristensen J; Soller M; Rödström EY; Ross OA; Toft M; Breedveld GJ; Bonifati V; Brodin L; Zettergren A; Sydow O; Linder J; Wirdefeldt K; Svenningsson P; Nissbrandt H; Belin AC; Forsgren L; Swanberg M
    Parkinsonism Relat Disord; 2019 Sep; 66():158-165. PubMed ID: 31422003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DNA resequencing array for genes involved in Parkinson's disease.
    Wilkins EJ; Rubio JP; Kotschet KE; Cowie TF; Boon WC; O'Hely M; Burfoot R; Wang W; Sue CM; Speed TP; Stankovitch J; Horne MK
    Parkinsonism Relat Disord; 2012 May; 18(4):386-90. PubMed ID: 22243833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population.
    Nuytemans K; Meeus B; Crosiers D; Brouwers N; Goossens D; Engelborghs S; Pals P; Pickut B; Van den Broeck M; Corsmit E; Cras P; De Deyn PP; Del-Favero J; Van Broeckhoven C; Theuns J
    Hum Mutat; 2009 Jul; 30(7):1054-61. PubMed ID: 19405094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exonic rearrangements in the known Parkinson's disease-causing genes are a rare cause of the disease in South African patients.
    van der Merwe C; Carr J; Glanzmann B; Bardien S
    Neurosci Lett; 2016 Apr; 619():168-71. PubMed ID: 27001088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive performance comparison of high-resolution array platforms for genome-wide Copy Number Variation (CNV) analysis in humans.
    Haraksingh RR; Abyzov A; Urban AE
    BMC Genomics; 2017 Apr; 18(1):321. PubMed ID: 28438122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.